SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-04-207277
Filing Date
2004-12-03
Accepted
2004-12-03 15:39:09
Documents
10
Period of Report
2004-03-27

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d10qa.htm 10-Q/A 25139
2 LICENSE AND OPTION AGREEMENT dex101.htm EX-10.1 306495
3 AMENDMENT NO. 2 TO LICENSE AND OPTION AGREEMENT dex103.htm EX-10.3 15449
4 AMENDMENT NO. 3 TO LICENSE AND OPTION AGREEMENT dex104.htm EX-10.4 105741
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER RULE 13A-14(A)/15D-14(A) dex311.htm EX-31.1 9557
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER RULE 13A-14(A)/15D-14(A) dex312.htm EX-31.2 9589
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 4154
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 4191
9 GRAPHIC g4633846338_img001.jpg GRAPHIC 11586
10 GRAPHIC g4633846338_img02.jpg GRAPHIC 10975
  Complete submission text file 0001193125-04-207277.txt   505891
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
OSCIENT PHARMACEUTICALS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-10824 | Film No.: 041183745
SIC: 2835 In Vitro & In Vivo Diagnostic Substances